 |
Some statistics
every year more than 1.1 million women worldwide unwanted breast cancer, a number that has nearly doubled since 1975 and is likely to increase in the foreseeable future diagnosed. United States, breast cancer is the second most common cancer (after skin cancer), affecting 250,000 women per year. It is the second leading cause of cancer share of 40,170 deaths per year - only deaths from lung cancer are more common in the U.S. population. This is certainly a public health priority and urgent epidemiological data of this kind, many argued that universal screening for breast cancer for all women at least once a year should be the norm. However, a more detailed investigation, this may not be the safest way, or prevent any disease.
The drawbacks of mammography Research On Blood Cells
This may seem a rather insensitive statement, and any person who has received an effective treatment for cancer after a mammogram detected abnormality tissue may find it strange, but the fact of the matter is that mammograms themselves are neither wholly reliable nor risk and can be particularly dangerous for women. An increased risk of developing the disease by genetic factors often an ambiguous result is proposing a "probably benign lesions", a result that provides the physician and the patient in a real dilemma. These patients are often repeated mammograms. Mammograms are probably false positives (which cause unnecessary suffering and alarm) and false negatives (with a worse situation for the patient, they are healthy believes produce, when in fact, cannot not be).
Mammograms to detect ionizing radiation changes in breast tissue that find physical examination alone will not be in a position that makes its strength and also its weakness. For example, a study suggested that some women can get with a genetic predisposition for breast cancer, the low doses of ionizing radiation during mammography to suffer significantly higher risk of developing cancer as a result of his. Young women between 25 and 29 years, a BRCA gene variant (mutates its normal function and predisposes carriers of the gene for breast cancer) have had no benefit at age obtained from the mammogram, but. Increasing the risk of creating diseases
It was a study of mathematical modeling, but other doctors share the concern about the indiscriminate use of mammography as a screening tool, says an expert, that up to 75% of cancer cases breast could by reducing or completely avoiding mammography X-rays and women vulnerable to the disease can be avoided. Obviously, if a medium could be developed, which allows an accurate diagnosis of breast cancer at an early stage without the harmful effects of ionizing radiation, which would be a very positive and valuable in the fight against this terrible disease.
An alternative diagnosis
luckily, as a medium that seems to be to be available on a large scale. Replace mammography with a blood test. Specifically, the test looks for traces of certain proteins (tumor antigens) in the blood. These proteins are the only correlation with certain types of breast cancer. The new test could be much more reliable than mammography and promised to recognize changes in cancer tissue at an early stage, when treatment likely to be effective. Any increase in these markers in the blood is higher than normal is a sign that the first changes under way, and the test seems to be very sensitive. In detecting these changes in blood biochemistry Researchers are developing are optimistic that cellular abnormalities seen much earlier than mammography in detecting minute changes in the levels of protein cancer marker test.
The test as a "BC-Seaport" is known and what. Impressive results in clinical trials, with a success rate of 95% To be precise, it measures the presence of no less than 22 tumor antigens (or "biomarkers") in serum provides a reliable differentiation between breast cancer and healthy patients. Developed and evaluated by medical laboratories Power3 the test seems very precise, safe and non-invasive. Conversely, women often mammograms painful and uncomfortable, because the process involves inevitably press and flatten the chest to get a clear picture of the man. Also more aware of body exposure of chest ritual uncomfortable and embarrassing Blood distributes these issues clearly and fully protects women from the dangerous exposure to ionizing radiation. Expected that the U.S. Food and Drug Administration have approved the study in the first half of 2010, after which it should. Easily accessible to the general public
a very similar test was developed by Provost Life Sciences, is available now and is a translation of biomarker test known (test or BT for short). British Columbia Power3 Seaport recognizes multiple serum biomarkers for breast cancer blood samples. Will have, in conjunction with a medical profile, the test result is produced by a single method of data analysis, the (so-called BT-score) patented score, an accurate measure of the presence or absence of cancer analyzed chest. Currently, the results that the test is somewhere near 80% accuracy, and improve efforts to match quality, is currently underway.
It is a major breakthrough in the fight against breast cancer?
Originally designed to just another "instrument of the doctor box" to complete the technical dominant image, the test is the promise of an important new asset diagnostics. It is perhaps too early to say at this stage - is the BT test in 41 countries available, of which 27 are to take the examination sent directly to consumers without a prescription - but can this new blood test for breast cancer is an important factor in the ongoing battle to defeat this terrible disease, tragic and painful and too often.
every year more than 1.1 million women worldwide unwanted breast cancer, a number that has nearly doubled since 1975 and is likely to increase in the foreseeable future diagnosed. United States, breast cancer is the second most common cancer (after skin cancer), affecting 250,000 women per year. It is the second leading cause of cancer share of 40,170 deaths per year - only deaths from lung cancer are more common in the U.S. population. This is certainly a public health priority and urgent epidemiological data of this kind, many argued that universal screening for breast cancer for all women at least once a year should be the norm. However, a more detailed investigation, this may not be the safest way, or prevent any disease.
The drawbacks of mammography Research On Blood Cells
This may seem a rather insensitive statement, and any person who has received an effective treatment for cancer after a mammogram detected abnormality tissue may find it strange, but the fact of the matter is that mammograms themselves are neither wholly reliable nor risk and can be particularly dangerous for women. An increased risk of developing the disease by genetic factors often an ambiguous result is proposing a "probably benign lesions", a result that provides the physician and the patient in a real dilemma. These patients are often repeated mammograms. Mammograms are probably false positives (which cause unnecessary suffering and alarm) and false negatives (with a worse situation for the patient, they are healthy believes produce, when in fact, cannot not be).
Mammograms to detect ionizing radiation changes in breast tissue that find physical examination alone will not be in a position that makes its strength and also its weakness. For example, a study suggested that some women can get with a genetic predisposition for breast cancer, the low doses of ionizing radiation during mammography to suffer significantly higher risk of developing cancer as a result of his. Young women between 25 and 29 years, a BRCA gene variant (mutates its normal function and predisposes carriers of the gene for breast cancer) have had no benefit at age obtained from the mammogram, but. Increasing the risk of creating diseases
It was a study of mathematical modeling, but other doctors share the concern about the indiscriminate use of mammography as a screening tool, says an expert, that up to 75% of cancer cases breast could by reducing or completely avoiding mammography X-rays and women vulnerable to the disease can be avoided. Obviously, if a medium could be developed, which allows an accurate diagnosis of breast cancer at an early stage without the harmful effects of ionizing radiation, which would be a very positive and valuable in the fight against this terrible disease.
An alternative diagnosis
luckily, as a medium that seems to be to be available on a large scale. Replace mammography with a blood test. Specifically, the test looks for traces of certain proteins (tumor antigens) in the blood. These proteins are the only correlation with certain types of breast cancer. The new test could be much more reliable than mammography and promised to recognize changes in cancer tissue at an early stage, when treatment likely to be effective. Any increase in these markers in the blood is higher than normal is a sign that the first changes under way, and the test seems to be very sensitive. In detecting these changes in blood biochemistry Researchers are developing are optimistic that cellular abnormalities seen much earlier than mammography in detecting minute changes in the levels of protein cancer marker test.
The test as a "BC-Seaport" is known and what. Impressive results in clinical trials, with a success rate of 95% To be precise, it measures the presence of no less than 22 tumor antigens (or "biomarkers") in serum provides a reliable differentiation between breast cancer and healthy patients. Developed and evaluated by medical laboratories Power3 the test seems very precise, safe and non-invasive. Conversely, women often mammograms painful and uncomfortable, because the process involves inevitably press and flatten the chest to get a clear picture of the man. Also more aware of body exposure of chest ritual uncomfortable and embarrassing Blood distributes these issues clearly and fully protects women from the dangerous exposure to ionizing radiation. Expected that the U.S. Food and Drug Administration have approved the study in the first half of 2010, after which it should. Easily accessible to the general public
a very similar test was developed by Provost Life Sciences, is available now and is a translation of biomarker test known (test or BT for short). British Columbia Power3 Seaport recognizes multiple serum biomarkers for breast cancer blood samples. Will have, in conjunction with a medical profile, the test result is produced by a single method of data analysis, the (so-called BT-score) patented score, an accurate measure of the presence or absence of cancer analyzed chest. Currently, the results that the test is somewhere near 80% accuracy, and improve efforts to match quality, is currently underway.
It is a major breakthrough in the fight against breast cancer?
Originally designed to just another "instrument of the doctor box" to complete the technical dominant image, the test is the promise of an important new asset diagnostics. It is perhaps too early to say at this stage - is the BT test in 41 countries available, of which 27 are to take the examination sent directly to consumers without a prescription - but can this new blood test for breast cancer is an important factor in the ongoing battle to defeat this terrible disease, tragic and painful and too often.
No comments:
Post a Comment